This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Inventor Ting Lian Chang: Pioneering Advances in Drug Delivery Systems
Introduction: Ting Lian Chang, based in Kaohsiung, Taiwan, is an innovative inventor known for his significant contributions to the field of drug delivery systems. With a focus on enhancing the efficacy of cell-penetrating peptides, Chang's work has the potential to revolutionize targeted therapy.
Latest Patents: Ting Lian Chang holds a patent titled "Oxidative modification improves the drugability of cell penetrating peptides as drug carriers." This invention introduces a cell-penetrating peptide dimer obtained through oxidative modification, where the monomers are linked by disulfide bonds. The patent emphasizes the enhanced drugability of the peptide dimer, highlighting improvements in stability, reduction of proteolysis, retention of permeability, and increased heparan sulfate binding specificity. The modified peptide products developed from this research serve as effective drug carriers, facilitating targeted delivery of therapeutic molecules.
Career Highlights: Although specific details about Ting Lian Chang's previous work experiences are not extensively documented, his patent exemplifies his commitment to innovation in the pharmaceutical field. Achieving a patent is a noteworthy milestone in Chang’s career, reflecting his expertise and dedication to improving drug delivery mechanisms through advanced biochemistry.
Collaborations: Throughout his career, Ting Lian Chang has had the opportunity to collaborate with talented individuals in his field. Among his colleagues are Yu-Min Lin and Wei-Chen Chen, who contribute to a collaborative atmosphere fostering innovation and research excellence.
Conclusion: Ting Lian Chang's work in developing superior drug delivery systems through oxidative modification of cell-penetrating peptides underscores his role as a key contributor to pharmaceutical innovation. His patent serves as a foundational step toward more effective targeted therapies, showcasing his commitment to enhancing the druggability of essential therapeutic agents. As he continues to innovate, Chang's research could play a pivotal role in advancing treatments for various medical conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile